Association Between Clonal Hematopoiesis of Indeterminate Potential and Brain β-Amyloid Deposition in Korean Patients With Cognitive Impairment
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Few studies have focused on the association between clonal hematopoiesis of indeterminate potential (CHIP) and β-amyloid (Aβ) deposition in the brain, which causes Alzheimer’s disease. We aimed to investigate the potential role of CHIP in brain Aβ deposition in Korean patients. We enrolled 58 Korean patients over 50 yrs of age with cognitive impairment who underwent brain Aβ positron emission tomography. We explored CHIP in their peripheral blood using deep-targeted next-generation sequencing. Irrespective of the presence or absence of brain Aβ deposition, mutations in DNMT3A and the C:G>T:A single-nucleotide variants were identified as the primary characteristics, which reflect aged hematopoiesis in the study population. Multivariate logistic regression revealed that the presence of CHIP was not associated with brain Aβ deposition. As both CHIP and brain Aβ deposition are associated with aging, further research is required to elucidate their possible interplay.
Abstract
Few studies have focused on the association between clonal hematopoiesis of indeterminate potential (CHIP) and β-amyloid (Aβ) deposition in the brain, which causes Alzheimer’s disease. We aimed to investigate the potential role of CHIP in brain Aβ deposition in Korean patients. We enrolled 58 Korean patients over 50 yrs of age with cognitive impairment who underwent brain Aβ positron emission tomography. We explored CHIP in their peripheral blood using deep-targeted next-generation sequencing. Irrespective of the presence or absence of brain Aβ deposition, mutations in DNMT3A and the C:G>T:A single-nucleotide variants were identified as the primary characteristics, which reflect aged hematopoiesis in the study population. Multivariate logistic regression revealed that the presence of CHIP was not associated with brain Aβ deposition. As both CHIP and brain Aβ deposition are associated with aging, further research is required to elucidate their possible interplay.
참고문헌 (20)
- Steensma DP, "Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes", Blood, 126, pp.9~16 (2015)
- Jaiswal S, "Age-related clonal hematopoiesis associated with adverse outcomes", N Engl J Med, 371, pp.2488~2498 (2014)
- Jaiswal S, "Clonal haematopoiesis : connecting ageing and inflammation in cardiovascular disease", Nat Rev Cardiol, 17, pp.137~144 (2020)
- Kim M, "Association between aortic valve sclerosis and clonal hematopoiesis of indeterminate potential", Ann Lab Med, 44, pp.279~288 (2024)
- Mas-Peiro S, "Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation", Eur Heart J, 41, pp.933~939 (2020)
- Dorsheimer L, "Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure", JAMA Cardiol, 4, pp.25~33 (2019)
- Buscarlet M, "DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions", Blood, 130, pp.753~762 (2017)
- Zink F, "Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly", Blood, 130, pp.742~752 (2017)
- Savola P, "Clonal hematopoiesis in patients with rheumatoid arthritis", Blood Cancer J, 8, pp.69~ (2018)
- Bouzid H, "Clonal hematopoiesis is associated with protection from Alzheimer’s disease", Nat Med, 29, pp.1662~1670 (2023)
- "Drugs@FDA: FDA-approved drugs. Amyvid/labels for NDA202008" (2012)[URL]
- "Drugs@FDA: FDA-approved drugs. Neuraceq/labels for NDA204677" (2014)[URL]
- "Drugs@FDA: FDA-approved drugs. Vizamyl/labels for NDA203137" (2013)[URL]
- Sabri O, "Beta-amyloid imaging with florbetaben", Clin Transl Imaging, 3, pp.13~26 (2015)
- Jessen F, "A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease", Alzheimers Dement, 10, pp.844~852 (2014)
- Petersen RC, "Clinical practice. Mild cognitive impairment", N Engl J Med, 364, pp.2227~2234 (2011)
- American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (2022), American Psychiatric Association
- Bolton KL, "Clonal hematopoiesis is associated with risk of severe Covid-19", Nat Commun, 12, pp.5975~ (2021)
- Moon I, "Clinical, mutational, and transcriptomic characteristics in elderly Korean individuals with clonal hematopoiesis driver mutations", Ann Lab Med, 43, pp.145~152 (2023)
- Alexandrov LB, "Signatures of mutational processes in human cancer", Nature, 500, pp.415~421 (2013)